Pro-inflammatory prostaglandins and progression of colorectal cancer
- 28 August 2008
- journal article
- review article
- Published by Elsevier in Cancer Letters
- Vol. 267 (2) , 197-203
- https://doi.org/10.1016/j.canlet.2008.03.004
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasisNature, 2007
- Aspirin and the Risk of Colorectal Cancer in Relation to the Expression of COX-2New England Journal of Medicine, 2007
- Crosstalk between peroxisome proliferator-activated receptor δ and VEGF stimulates cancer progressionProceedings of the National Academy of Sciences, 2006
- 15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesisProceedings of the National Academy of Sciences, 2006
- Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention TrialNew England Journal of Medicine, 2005
- Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma PreventionNew England Journal of Medicine, 2005
- Complications of the COX-2 Inhibitors Parecoxib and Valdecoxib after Cardiac SurgeryNew England Journal of Medicine, 2005
- A Randomized Trial of Aspirin to Prevent Colorectal Adenomas in Patients with Previous Colorectal CancerNew England Journal of Medicine, 2003
- Inflammation and cancerNature, 2002
- NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, EICOSANOIDS, AND COLORECTAL CANCER PREVENTIONGastroenterology Clinics of North America, 1996